-$2.2M
Value of Insider Transactions in the last 2 years

Sign up to access historical data

Sign up

Insider Transactions

Name Transaction Date Sold / Bought Shares Price Value
Abate KristinOct 1, 2025Sell362$6.296$2,300
Paulson Richard A.Sep 15, 2025Sell1,257$6.43$8,100
Mano MichaelSep 15, 2025Sell234$6.43$1,500
Poulton StuartSep 15, 2025Sell401$6.43$2,600
Rangwala ReshmaSep 15, 2025Sell408$6.43$2,600
Cheng Sohanya RoshanSep 15, 2025Sell325$6.43$2,100
Abate KristinSep 15, 2025Sell23$6.43$150
Abate KristinSep 3, 2025Sell12$6.78$81
Poulton StuartJul 29, 2025Sell191$4.37$830
Abate KristinJul 22, 2025Sell238$4$950
Paulson Richard A.May 6, 2025Sell236$7.12$1,700
Rangwala ReshmaApr 23, 2025Sell419$6.17$2,600
Paulson Richard A.Apr 4, 2025Sell245$3.74$920
Paulson Richard A.Mar 4, 2025Sell11,694$6.29$74,000
Cheng Sohanya RoshanMar 4, 2025Sell3,445$6.29$22,000
Rangwala ReshmaMar 4, 2025Sell3,587$6.29$23,000
Poulton StuartMar 4, 2025Sell3,548$6.29$22,000
Mano MichaelMar 4, 2025Sell2,793$6.29$18,000
Abate KristinMar 4, 2025Sell571$6.29$3,600
Poulton StuartFeb 18, 2025Sell5,914$0.63$3,700
Paulson Richard A.Feb 4, 2025Sell4,099$0.65$2,700
Paulson Richard A.Jan 6, 2025Sell4,055$0.783$3,200
Paulson Richard A.Dec 4, 2024Sell3,620$0.81$2,900
Paulson Richard A.Nov 5, 2024Sell3,675$0.9106$3,300
Paulson Richard A.Oct 4, 2024Sell3,607$0.8793$3,200
Mano MichaelSep 4, 2024Sell3,971$0.7218$2,900
Paulson Richard A.Sep 4, 2024Sell3,667$0.7218$2,600
Mason MichaelSep 4, 2024Sell7,050$0.7218$5,100
Cheng Sohanya RoshanSep 4, 2024Sell5,356$0.7218$3,900
Paulson Richard A.Aug 6, 2024Sell3,608$0.9299$3,400
Poulton StuartJul 30, 2024Sell2,883$1.06$3,100
Paulson Richard A.Jul 5, 2024Sell3,616$0.851$3,100
PAKIANATHAN DEEPIKAJun 7, 2024Sell229,308$0.9507$220,000
PAKIANATHAN DEEPIKAJun 7, 2024Sell2,240$0.9507$2,100
PAKIANATHAN DEEPIKAJun 6, 2024Sell117,307$0.9828$120,000
PAKIANATHAN DEEPIKAJun 6, 2024Sell1,145$0.9828$1,100
PAKIANATHAN DEEPIKAJun 5, 2024Sell463,518$0.9582$440,000
PAKIANATHAN DEEPIKAJun 5, 2024Sell4,526$0.9582$4,300
PAKIANATHAN DEEPIKAJun 4, 2024Sell337,742$0.9521$320,000
Paulson Richard A.Jun 4, 2024Sell3,592$0.99$3,600
PAKIANATHAN DEEPIKAJun 4, 2024Sell3,298$0.9521$3,100
Mason MichaelJun 4, 2024Sell652$0.99$650
PAKIANATHAN DEEPIKAJun 3, 2024Sell357,256$1.0007$360,000
PAKIANATHAN DEEPIKAJun 3, 2024Sell3,488$1.0007$3,500
PAKIANATHAN DEEPIKAMay 31, 2024Sell202,418$0.954$190,000
PAKIANATHAN DEEPIKAMay 31, 2024Sell1,976$0.954$1,900
Paulson Richard A.May 6, 2024Sell3,576$1.13$4,000
Rangwala ReshmaApr 22, 2024Sell6,789$1.17$7,900
Paulson Richard A.Apr 4, 2024Sell3,563$1.29$4,600
Paulson Richard A.Mar 5, 2024Sell3,573$1.3$4,600
Paulson Richard A.Mar 1, 2024Sell19,374$1.2$23,000
Rangwala ReshmaMar 1, 2024Sell5,969$1.2$7,200
Poulton StuartMar 1, 2024Sell6,155$1.2$7,400
Mason MichaelMar 1, 2024Sell6,162$1.2$7,400
Mano MichaelMar 1, 2024Sell3,576$1.2$4,300
Cheng Sohanya RoshanMar 1, 2024Sell5,109$1.2$6,100
Rangwala ReshmaFeb 29, 2024Sell15,667$1.17$18,000
Poulton StuartFeb 29, 2024Sell16,311$1.17$19,000
Mason MichaelFeb 29, 2024Sell27,687$1.17$32,000
Mano MichaelFeb 29, 2024Sell16,973$1.17$20,000
Cheng Sohanya RoshanFeb 29, 2024Sell21,840$1.17$26,000
Paulson Richard A.Feb 29, 2024Sell80,470$1.17$94,000
Mason MichaelFeb 27, 2024Sell2,545$1.3238$3,400
Poulton StuartFeb 15, 2024Sell5,748$1.33$7,600
Poulton StuartFeb 15, 2024Sell99$1.4$140
Mason MichaelFeb 6, 2024Sell4,205$1.5865$6,700
Paulson Richard A.Feb 6, 2024Sell4,012$1.5865$6,400
Paulson Richard A.Jan 4, 2024Sell4,114$0.82$3,400
Paulson Richard A.Dec 4, 2023Sell3,622$0.79$2,900
Paulson Richard A.Nov 6, 2023Sell3,606$0.9203$3,300

What's the latest insider transaction for Karyopharm Therapeutics?

The most recent insider transaction for Karyopharm Therapeutics was conducted by Abate Kristin, who sold 362 shares on October 1, 2025 at a price of $6.30 per share.

Which insider has sold the most KPTI stock over the last two years?

PAKIANATHAN DEEPIKA has sold the most KPTI stock in the last 2 years, with a total value of $1.7M.

What is the total value of insider transactions for Karyopharm Therapeutics (KPTI) in the last 2 years?

The total value of insider transactions for Karyopharm Therapeutics in the last 2 years is negative, amounting to -$2.2M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

How do insider transactions over the last 2 years reflect on Karyopharm Therapeutics' market confidence?

Over the last 2 years, insider transactions for Karyopharm Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.

Why is monitoring insider trading activity important for investors?

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.